Last edition
News about Global Pharma
Fosun Pharma Industrial has signed a global License Agreement with Expedition Therapeutics Inc., granting the US-based biotechnology company the rights to develop, manufacture, and commercialise its investigational respiratory drug XH-S004 in all regions worldwide, excluding the Chinese Mainland, Hong Kong SAR, and Macau SAR.
Global Pharma | 13/08/2025 | By Dineshwori | 376
Sandoz Partners with Elawan Energy to Decarbonize European Operations
Sandoz has signed a 10-year virtual Power Purchase Agreement (PPA) with Elawan Energy to co-develop 150 MW of new solar projects in Valladolid, Castilla y Leon, Spain.
Global Pharma | 12/08/2025 | By Dineshwori | 278
Amphastar Secures FDA Approval for Generic Iron Sucrose Injection
The US FDA has approved Amphastar's Abbreviated New Drug Application (ANDA) for iron sucrose injection, an iron replacement product indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease.
Global Pharma | 12/08/2025 | By Dineshwori | 348
Lupin launches Glucagon for Injection USP, 1 mg/Vial in US Market
Lupin has launched its Glucagon for Injection USP, 1mg/vial emergency kit in the US, a bioequivalent to Eli Lilly’s product, for treating severe hypoglycemia and aiding certain radiologic procedures.
Global Pharma | 12/08/2025 | By Mrinmoy Dey | 157
Ono Pharmaceutical has signed a definitive agreement with Seikagaku Corporation for the co-development and exclusive marketing of Gel-One for osteoarthritis treatment in Japan.
Global Pharma | 11/08/2025 | By Mrinmoy Dey | 391
Zydus Secures Final USFDA Approval for Diltiazem Hydrochloride Tablets
Zydus Lifesciences has received final USFDA approval to market Diltiazem Hydrochloride Tablets in 30 mg, 60 mg, 90 mg, and 120 mg dosages for the treatment of chronic stable angina and angina due to coronary artery spasm in the US.
Global Pharma | 11/08/2025 | By Mrinmoy Dey | 213
Canadian biotechnology company Cardiol Therapeutics has announced topline results from its ARCHER Phase II clinical trial evaluating CardiolRx in patients with acute myocarditis.
Global Pharma | 08/08/2025 | By Dineshwori | 224
The US Food and Drug Administration (FDA) has granted accelerated approval for Jazz Pharmaceuticals' Modeyso (dordaviprone) for the treatment of adult and pediatric patients 1 year of age and older with H3 K27M-mutant diffuse midline glioma – a rare and highly aggressive brain tumour – with progressive disease following prior therapy.
Global Pharma | 08/08/2025 | By Dineshwori | 563
Freenome Partners with Exact Sciences to Commercialise Blood-Based Colorectal Cancer Test
Freenome has entered into an exclusive license agreement with Exact Sciences to advance the commercialisation of its colorectal cancer (CRC) blood-based screening test.
Global Pharma | 08/08/2025 | By Dineshwori | 873
Emcure Pharma Delivers Robust Performance Across All Businesses in Q1FY26: Satish Mehta
Emcure Pharmaceuticals reported strong financial results for the first quarter of FY26, demonstrating impressive growth in both domestic and international businesses.
Global Pharma | 07/08/2025 | By Dineshwori | 567
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy